Foley Represents DLB in Sale of Majority Stake to Accenture

Foley & Lardner LLP represented DLB Associates and its affiliated companies (collectively “DLB”), an industry leader and trailblazer in engineering and consulting services for data centers and related mission critical facilities, in the sale of a majority stake to Accenture (NYSE: ACN). The acquisition of DLB expands Accenture’s end-to-end data center capabilities to help software, […]
Foley Represents TCGX as Investor in $287M Series D1 Financing for CORXEL

Foley & Lardner LLP represented TCGX Crossover (TCGX) as an investor in the $287 million Series D1 financing for CORXEL, a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients with cardiometabolic conditions around the world. In addition to TCGX, the round included new investors, including SR One, RA Capital Management, HBM Healthcare Investments, […]